Group B Streptococcus (GBS) colonizes mucosal surfaces of the human gastrointestinal and gynecological tracts and causes disease in a wide range of patients. Invasive illness occurs after organisms cross an epithelial boundary and enter deeper tissues. The broad scientific goal of this project is to better characterize the molecular events occurring during interaction of alpha-like proteins (Alps) on the surface of GBS with epithelial cells. Alpha C protein (ACP) is the prototype of this family of highly conserved Gram-positive bacterial surface proteins sharing similar N-terminal regions and long tandem repeating regions. Prior work shows ACP binds to cervical epithelial cells, mediates GBS entry into these cells, and contributes to GBS movement across a multi-layer configuration of these cells. The ACP N-terminal region is particularly implicated in these events. Both full ACP and the N-terminal region induce protective antibody responses in a mouse model of infection. Preliminary studies suggest that exposure of epithelial cells to free ACP or to live GBS expressing surface ACP results in actin-dependent accumulation of intracellular ACP. Additional preliminary work indicates Alp3 protein, with 78% identity to ACP in the N terminal region, shares similar functions to ACP. These data support a hypothesis that Alps trigger actin-dependent internalization of GBS through interaction of an Alp N-terminal domain with an epithelial receptor.
The specific aims of this proposal are 1. to identify the molecular events allowing accumulation of cell-associated Alps over time by assessing the impact of interference with specific Rho GTPase-mediated actin rearrangements, 2. to map important ACP epitopes for epithelial cell interaction by producing altered versions of the ACP N-terminal region and comparing their functions to those of native ACP, and 3. to assess the efficacy of the ACP variants as vaccines or as pharmacologic agents in preventing invasive disease in a mouse model of GBS infection. The training goal of this project is to prepare the applicant for a career as a physician/scientist performing independent investigation in the field of cellular microbiology/bacterial pathogenesis, by providing didactic education and the opportunity to develop laboratory expertise in this field. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI059495-02
Application #
6916561
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Rubin, Fran A
Project Start
2004-07-01
Project End
2009-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
2
Fiscal Year
2005
Total Cost
$117,720
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Chang, Yung-Chi; Wang, Zhipeng; Flax, Lindsay A et al. (2011) Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. PLoS Pathog 7:e1002082
Wang, Zhipeng; Flax, Lindsay A; Kemp, Melissa M et al. (2011) Host and pathogen glycosaminoglycan-binding proteins modulate antimicrobial peptide responses in Drosophila melanogaster. Infect Immun 79:606-16
Baron, Miriam J; Wong, Sandra L; Nybakken, Kent et al. (2009) Host glycosaminoglycan confers susceptibility to bacterial infection in Drosophila melanogaster. Infect Immun 77:860-6
Baron, Miriam J; Filman, David J; Prophete, Gina A et al. (2007) Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B Streptococci into host cells. J Biol Chem 282:10526-36
Baron, Miriam J; Kasper, Dennis L (2005) Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells. J Clin Invest 115:2325-7